Ms. Stacey Luo is a pharmacist who is specialized in Oncology in New York, New York. Patients can reach her at 1275 York Ave, Pharmacy Dept., New York or contact her on 212-639-8464. Active license number of Ms. Stacey Luo is 048576 for Oncology in New York. Ms. Stacey Luo is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Ms. Stacey Luo speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Ms. Stacey Luo
Specialization:
Oncology
Credentials:
RPH
Gender:
Female
Location:
1275 York Ave, Pharmacy Dept., New York, New York, 10021-6007
Phone:
212-639-8464
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Ms. Stacey Luo are as mentioned below.
NPI Number:
1578764122
NPI Enumeration Date:
30 May, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ms. Stacey Luo are as mentioned below.
Specialization
License Number
State
Status
Oncology
048576
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
167 E 67th St, Apt 16d New York, New York
Zip:
10021-5914
Phone Number:
646-284-7885
Fax Number:
--
Patients can reach Ms. Stacey Luo at 1275 York Ave, Pharmacy Dept., New York, New York or can call on phone at 212-639-8464.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.